- Recent Funding
- Investors
- Shanghai Angel Club
Shanghai Angel Club portfolio
Shanghai Angel Club has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Shanghai Peptide Biotechnology's Seed round in November 2026, alongside Tianyou Investment and FineWill Capital. By category, its portfolio leans toward Health and bio (2) and AI coding and devtools (1).
What Shanghai Angel Club invests in
- Health and bio · 2 · 100%
- AI coding and devtools · 1 · 50%
- Developer tools and cloud · 1 · 50%
How Shanghai Angel Club invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Seed | 1 100% | undisclosed |
Shanghai Angel Club portfolio companies
SShanghai Peptide BiotechnologySeed · Nov 2026TTushen Zhihebacker
| Company | Round with Shanghai Angel Club | Total raised | Latest raise |
|---|---|---|---|
| SShanghai Peptide Biotechnology AI coding and devtools |
Seed | undisclosed | Nov 10, 2026 Seed |
Health and bio |
backer | undisclosed | Nov 9, 2026 Seed |
Most frequent co-investors
- TTianyou Investment1 shared round · last Nov 10, 2026
FFineWill Capital1 shared round · last Nov 10, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Shanghai Angel Club. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Shanghai Angel Club, which is a subset of its real portfolio. API: /api/v1/investors/shanghai-angel-club (get a free API key). More: the most active VC firms and new venture capital funds.